TJ-137 administered to patients with chronic ITP increased the platelet count "slightly" or more in 31.7% of the patients and showed a clinical effect in 40.9% with a rating of "modestly effective" or better. With a low incidence of adverse reactions, TJ-137 is ex pected to be a new drug for the treatment of ITP.
McMillan R.Chronic idiopathic thrombocytopenic purpura. N Engl J Med1981;304:1135-47.
3.
Yasunaga K.Statistical observations of the treatment of chronic ITP. The 1978 Annual Report of the Idiopathic Dyshematopoiesis Research Team, 1979 ; pp. 532-42.
4.
Tsuruta M., Kodama A., Kanamori S., et al. Case report: a female child with idiopathic thrombocytopenic purpura in whom a kampo preparation seemed effective. Pediatr Intern Med1984;16:66-9.
5.
Okushin H.Case report: a patient with idiopathic thrombocytopenic purpura in whom concomitant Kami-kihi-to enabled maintenance therapy. Kampo Shinryo1990;9:24-8.
6.
Imbach P., Barandun S., d'Apuzzo V., et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet1981;i:1228-31.
7.
Ahn YS, Harrington WJ, Simon SR, Mylvaganam R., Pall LM, So AGDanazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med1983;308:1396-9.
8.
Nomura T., Maekawa T., Dan K.Treatment of idiopathic thrombocytopenic purpura with danazol: a multicenter study. 1984 Annual Report of the Idiopathic Dyshematopoiesis Research Team, 1985; pp. 344-50.
9.
Nomura S., Yanabu M., Fukuroi C., et al. Comparison of therapeutic effects of three drugs (neurotropin, ascorbate, Kami-kihi-to) for idiopathic thrombocytopenic purpura. Ther Res1992;13:2433-41.
10.
Kuramoto A., Fujimura K., Takada N., Nomura T.Multicenter pilot study of the effects of ascorbate in refractory ITP. 1989 Annual Report of the Idiopathic Thrombocytopenic Research Team, 1990; pp. 124-7.
11.
Obata S., Kimura K., Maeda K.Case report: a patient with idiopathic thrombocytopenic purpura in whom concomitant Sairei-to was useful to reduce the dose of adreno-cortical hormone. Jpn J Oriental Med1990;41:99-101.
12.
Araikawa K. , Matsuzawa H., Sakurada T., Kato K., Kashiwakura C.Clinical investigation of Tsumura Sho-saiko-to in idiopathic thrombocytopenic purpura (ITP). Kampo Igaku1990;14:204-6.
13.
Araikawa K. , Katsushima I., Sakurada T., Kato K., Furukawa Y.Effect of Tsumura Sho-saiko-to on idiopathic thrombocytopenic purpura (ITP). Kampo Igaku1991;15:402-5.
14.
Nakamura S. , Yabe H., Nagai K.Treatment of idiopathic thrombocytopenic purpura with kampo medicine. Gendai Toyo Igaku1991 ;12(1):160-3.
15.
Chikuda K., Suenaga T.Therapeutic effect of Sairei-to in idiopathic thrombocytopenic purpura . Gendai Toyo Igaku1991;12(1):164-9.
16.
Wada H., Yokoyama T., Kobayashi M., et al. Experience in the treatment of idiopathic thrombocytopenic purpura with Tsumura Sho-saiko-to. Kampo Igaku1992 ;16:425-7.
17.
Sakuragawa N. , Ejiri N., Hayakawa Y., Furuoka Y., Nakagawa M., Shimazaki C.Kami-kihi-to, its therapeutic effect in ITP patients and effect of IL-6 production in mice . Proceedings of the 9th Congress of the Society of Wakan Yaku, 1992; p. 96.
18.
Nomura S., Yamaguchi K., Kido H., et al. Effects of Kami-kihi-to on antiplatelet antibodies and immune complexes in ITP patients. Proceedings of the 9th Congress of the Medical and Pharmaceutical Society for Wakan Yaku, 1992; p. 95.
